Insights
The Association of the British Pharmaceutical Industry (ABPI) has issued a policy proposal aimed at supporting the delivery of the NHS 10-Year Plan.
13 May 2025The plan is built around three core shifts in care: from hospital to community, from analogue to digital, and from treatment to prevention. These shifts reference the government’s ambition to deliver economic growth through improved health outcomes.
AI and copyright - moving closer to a solution?
19 Nov 2024Lawmakers are addressing how to govern the use of copyrighted materials for training AI models. This article examines the situation in the UK and Europe.
What can we expect from the new era of clinical trials in the UK?
23 Jan 2025It is hoped that changes to legislation on clinical trials in the UK will quicken the trial approvals process and foster innovation in trial design without compromising patient safety. The amending legislation has been made and will apply in early 2026.
Pharmaceuticals and Life Sciences: what will 2025 bring?
12 Dec 2024As things quieten down for the end of the year (ha ha, one day maybe but not 2024!), it is good to reflect on what is next. In this article, we have pointed towards a few key developments to watch out for in 2025.
Changes to UK medical devices regulation: What is on the horizon for 2025?
23 Jan 2025The Medicines and Healthcare products Regulatory Agency (MHRA) recently published a roadmap which sets out the revised timeline for implementing reforms to the UK's medical devices regulatory framework.
Key Deadlines for the Windsor Framework: what you need to know about medicine regulations
25 Sept 2024Marketing authorisation holders (MAHs) are required to take specific actions regarding their product licenses in Northern Ireland (NI) and Great Britain (GB) by 30 September 2024 to avoid potential regulatory complications.
